| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 276.22B | 269.01B | 285.39B | 292.95B | 243.44B | 206.44B |
| Gross Profit | 28.77B | 31.06B | 29.76B | 28.41B | 20.17B | 12.87B |
| EBITDA | 15.32B | 16.73B | 21.59B | 14.23B | 14.19B | 5.16B |
| Net Income | 9.94B | 9.30B | 11.31B | 5.42B | 5.82B | -2.06B |
Balance Sheet | ||||||
| Total Assets | 160.73B | 170.37B | 173.05B | 183.31B | 170.67B | 159.00B |
| Cash, Cash Equivalents and Short-Term Investments | 41.56B | 45.69B | 43.68B | 39.19B | 34.11B | 32.41B |
| Total Debt | 10.97B | 6.42B | 14.52B | 14.84B | 22.82B | 25.03B |
| Total Liabilities | 68.41B | 64.47B | 74.86B | 87.01B | 84.19B | 79.81B |
| Stockholders Equity | 91.27B | 104.89B | 96.28B | 89.78B | 80.37B | 72.86B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.81B | 5.30B | 14.80B | 239.00M | -4.35B |
| Operating Cash Flow | 0.00 | 13.58B | 9.76B | 18.45B | 3.74B | -354.00M |
| Investing Cash Flow | 0.00 | -3.59B | 3.96B | -2.08B | 6.67B | 2.01B |
| Financing Cash Flow | 0.00 | -12.37B | -9.29B | -13.37B | -10.01B | -812.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥240.16B | 8.29 | ― | 3.36% | 4.89% | 43.96% | |
78 Outperform | ¥74.74B | 4.15 | 11.87% | 5.00% | -5.74% | -17.86% | |
71 Outperform | ¥90.64B | 4.18 | ― | 3.88% | -4.13% | 158.47% | |
70 Outperform | ¥385.71B | 12.15 | ― | 1.60% | -0.11% | -21.86% | |
68 Neutral | ¥212.29B | 21.03 | ― | 4.77% | -3.95% | -13.75% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥401.32B | -20.09 | 3.70% | 3.42% | 4.24% | 39.02% |